5-Amino-1MQ
Very early researchGet notified when the evidence changes.
The research is at the earliest stage – mostly cells in a lab dish. It is far too early to say much.
Compiled and reviewed by the PeptideSearch Editorial Team · Status checked 2026-08-04
Also called 5-amino-1-methylquinolinium
A small molecule, not a peptide. Blocks an enzyme involved in fat storage. Only tested in cells and mice.
Official status: Not nominated for 503A compounding · Checked 2026-08-04
Can a doctor prescribe this?
- Small pharmacy (503A)
- Never put forward to FDA
- Large outsourcing facility (503B)
- Never put forward to FDA
Not approved anywhere and not on the compounding list.
503A is a pharmacy making a single prescription for one patient. 503B is a facility making batches. They are governed by separate lists. Where a category is shown, it is a position on the FDA's list of substances that have been put forward and are still being worked through — not the final list, which is set by rulemaking. Category 1 means the FDA does not plan to act against a pharmacy that makes it while the review runs.
Lab suppliers we list: 12
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
No dosing information has been published in the research indexed here.
- Animal study, rats or miceNAD<sup>+</sup> metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer.
Journal for immunotherapy of cancer · 2024
- Animal study, rats or miceReduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice.
Scientific reports · 2022
- Lab dish studySmall molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2021
Spot an error? corrections@peptidesearch.org